logo
Select company
Select metric
-80.01%Return on Assets
VS
Market
9
Sector
26
Industry
35
History
18
$ 1.42Close
$ 1.42 - $ 4.45 52-Week Range
Ticker Information

Ticker

APRE

Company Name

APREA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

APREA THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

APRE - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 17.31M$ -13.85M-80.01%
3/31/2025$ 20.22M$ -14.08M-69.63%
12/31/2024$ 23.98M$ -12.96M-54.04%
9/30/2024$ 26.89M$ -13.51M-50.22%
6/30/2024$ 29.96M$ -12.93M-43.14%
3/31/2024$ 33.2M$ -12.72M-38.3%
12/31/2023$ 22.65M$ -14.29M-63.08%
9/30/2023$ 25.77M$ -13.29M-51.56%
6/30/2023$ 28.68M$ -14.11M-49.18%
3/31/2023$ 32.02M$ -109.11M-340.74%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • APREA THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -49.75%.
  • Over the past 5 years, APREA THERAPEUTICS INC's average ROA has been -115.79%.
  • The median ROA for APREA THERAPEUTICS INC during this period was -65.95%
  • APREA THERAPEUTICS INC reached its highest ROA over the past 5 years at -38.3%.
  • The lowest ROA recorded by APREA THERAPEUTICS INC in the same timeframe -373.6%

APREA THERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
LYRA : LYRA THERAPEUTICS INC -73.87%SXTP : 60 DEGREES PHARMACEUTICALS INC -198.46%BRTX : BIORESTORATIVE THERAPIES INC -125.92%VYNE : VYNE THERAPEUTICS INC -86.2%ERNA : ERNEXA THERAPEUTICS INC -576.48%PAVM : PAVMED INC 159.59%CODX : CO-DIAGNOSTICS INC -77.46%LEXX : LEXARIA BIOSCIENCE CORP -168.97%POAI : PREDICTIVE ONCOLOGY INC -284.62%HCWB : HCW BIOLOGICS INC -74.56%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for APREA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -51.16M ] / Assets [ $ 102.83M ]
(=) ROA [ -49.75% ]

APRE - Return on Assets, Last 5 years

-373.6%

Minimum

Dec 31, 2022

-38.3%

Maximum

Mar 31, 2024

-115.79%

Average

-65.95%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.44K
min-33.4%
max33.98%
average0.12%
median1.53%
std10.61%